The free dividend tracker to help you grow your wealth. Link your brokerage accounts and MerryDiv automatically syncs your holdings and dividends.
Data last updated: Oct 12, 2026
Snapshot (as of Oct 12, 2026): Roche Holding AG (RHHBY) pays a $9.80 annual dividend, yielding 2.86% at $54.09/share. Next ex-dividend date 2026-03-13. 8 consecutive years of dividend growth. Source: Yahoo Finance, aggregated by MerryDiv.
Dividend Yield: 2.86%
Annual Dividend: $9.80 per share
Payout Ratio: 64.6%
Ex-Dividend Date: 2026-03-13
Dividend Frequency: annually
Sector: Healthcare
Years of Dividend History: 34
Roche Holding AG dividend income comes from one of the world's oldest and largest healthcare companies, founded in 1896 and headquartered in Basel, Switzerland. The company operates across pharmaceuticals, targeting oncology, neuroscience, and immunology, and diagnostics, where it develops tests for cancer, diabetes, and infectious diseases. RHHBY pays an annual dividend of $1.23 per share, with the next ex-dividend date on March 13, 2026, and a current yield of 2.75%. A beta of 0.347 means the stock moves far less than the broader market, which suits income investors who prioritize low volatility over high yield.
Roche Holding AG pays out 68.5% of earnings as dividends, a payout ratio classified as elevated (60–75%). That level is supported by a business spanning both pharmaceutical therapies and a broad diagnostics segment, including laboratory tests and instruments that serve recurring clinical demand across hospitals and healthcare systems worldwide. Roche Holding AG dividend safety faces its main pressure from that payout ratio sitting near the upper end of the elevated range, leaving limited room to absorb an earnings decline without affecting the dividend.
Roche Holding AG dividend history shows a CAGR of -2.8% per year from 2008 to 2025. Per-share payments moved from $2.2519 at the start of the window to $1.3890 by 2025 (the 2026 figure of $1.5495 is a partial year and excluded from the CAGR calculation, per Roche Holding AG dividend 2026 data). The largest annual increase in the window was 27.1% in 2011, but the window also contains at least one year-over-year decline exceeding 5%, and the overall trend across the full period is negative.
| Period | CAGR | From | To |
|---|---|---|---|
| 3-Year | +3.8% | $1.24 (2022) | $1.39 (2025) |
| 5-Year | +4.1% | $1.14 (2020) | $1.39 (2025) |
| 10-Year | +3.3% | $1.00 (2015) | $1.39 (2025) |
RHHBY fits dividend investors who want low market volatility and a moderate yield from a globally diversified healthcare business. The current yield of 2.75% sits above the 5-year average of 2.46%, meaning today's entry point offers slightly more income than the historical norm. The trade-off is clear: the dividend's long-term CAGR is negative at -2.8%, so purchasing power from the payout has eroded over time. A yield classification of moderate (2–4%) and an elevated payout ratio of 68.5% describe a stock that delivers present income but limited dividend growth. Roche Holding AG stock suits investors who value sector breadth and low beta over rising distributions.
| Payment Date | Amount per Share |
|---|---|
| 2026-03-13 | $1.5495 |
| 2025-03-28 | $1.3890 |
| 2024-03-14 | $1.3494 |
| 2023-03-16 | $1.2794 |
| 2022-03-17 | $1.2407 |
| 2021-03-18 | $1.2206 |
| 2020-03-19 | $1.1366 |
| 2019-03-07 | $1.0746 |
| 2018-03-15 | $0.8918 |
| 2017-03-15 | $0.8458 |
| Year | Total Dividends |
|---|---|
| 2026 | $1.5495 |
| 2025 | $1.3890 |
| 2024 | $1.3494 |
| 2023 | $1.2794 |
| 2022 | $1.2407 |
Project income from RHHBY with the RHHBY dividend calculator or track your full portfolio with the dividend tracker.